US Marks Biologics Transition Day

FDA Sees 96 Drugs Make The Move To Biologics Regulation

 
• By Sue Sutter
  
Open wooden door to the new world with green environment. Climate change concept.
The FDA’s door is now open to applications for biosimilar and interchangeable insulins • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation